# Clinical Investigation to Evaluate the Safety and Performance of ConnettivinaBio Plus Cream Compared to ConnettivinaBio Cream in the Management of Wounds in Patients at High Risk of Infection

> **NCT04936204** · NA · UNKNOWN · sponsor: **Fidia Farmaceutici s.p.a.** · enrollment: 80 (estimated)

## Conditions studied

- Wounds

## Interventions

- **DEVICE:** ConnettivinaBio Plus cream
- **DEVICE:** ConnettivinaBio cream

## Key facts

- **NCT ID:** NCT04936204
- **Lead sponsor:** Fidia Farmaceutici s.p.a.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-10
- **Primary completion:** 2024-04
- **Final completion:** 2024-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04936204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04936204, "Clinical Investigation to Evaluate the Safety and Performance of ConnettivinaBio Plus Cream Compared to ConnettivinaBio Cream in the Management of Wounds in Patients at High Risk of Infection". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04936204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*